Albumedix

With more than 30 years of experience, Albumedix are proud to be recognized as one of the leaders in recombinant human albumin products and technologies. Albumedix enables the effective formulation of otherwise hard-to-stabilize drugs, cell therapies, and vaccines. Their albumin-based tech­nologies offer new ways of optimizing drug dosing and enhancing therapeutic performance by increasing the half-life, payload capacity, and tissue specific delivery of active pharmaceutical agents. This results in simpler treatment regi­mens, better performance, and, ultimate­ly, improved patient outcomes. Albumedix is headquartered in Nottingham, UK, with both research and large-scale manufacturing facilities. They are all committed to improving patient quality of life and are just as passionate about albumin and albumin-enabled therapies today as they were when they started 30 years ago.

With more than 30 years of experience, Albumedix are proud to be recognized as one of the leaders in recombinant human albumin products and technologies. Albumedix enables the effective formulation of otherwise hard-to-stabilize drugs, cell therapies, and vaccines. Their albumin-based tech­nologies offer new ways of optimizing drug dosing and enhancing therapeutic performance by increasing the half-life, payload capacity, and tissue specific delivery of active pharmaceutical agents. This results in simpler treatment regi­mens, better performance, and, ultimate­ly, improved patient outcomes. Albumedix is headquartered in Nottingham, UK, with both research and large-scale manufacturing facilities. They are all committed to improving patient quality of life and are just as passionate about albumin and albumin-enabled therapies today as they were when they started 30 years ago.

Contact Albumedix

Albumedix Ltd. Mabel Street The Meadows Nottingham NG2 3ED, United Kingdom

Website link